Cargando…
Nitrofurantoin and glucose-6-phosphate dehydrogenase deficiency: a safety review
Nitrofurantoin, a broad-spectrum antibiotic available since 1953, is used widely for the treatment of urinary tract infections as it often retains activity against drug-resistant uropathogens. It is contraindicated in pregnant women at term, and in neonates. Like trimethoprim/sulfamethoxazole, nitro...
Autores principales: | Recht, Judith, Chansamouth, Vilada, White, Nicholas J., Ashley, Elizabeth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070801/ https://www.ncbi.nlm.nih.gov/pubmed/35529053 http://dx.doi.org/10.1093/jacamr/dlac045 |
Ejemplares similares
-
Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries
por: Recht, Judith, et al.
Publicado: (2018) -
Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia
por: Valencia, Sócrates Herrera, et al.
Publicado: (2016) -
Acquired Glucose-6-Phosphate Dehydrogenase Deficiency
por: Pes, Giovanni Mario, et al.
Publicado: (2022) -
Erratum to: Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia
por: Valencia, Sócrates Herrera, et al.
Publicado: (2016) -
Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiency
por: Nantakomol, Duangdao, et al.
Publicado: (2013)